Approvals/TGA/MYTOLAC lanreotide (as acetate) 120 mg solution for injection pre-filled syringe

Approved

STANDARD

MYTOLAC lanreotide (as acetate) 120 mg solution for injection pre-filled syringe

Amdipharm Mercury Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: d4746129aa484191
Product Name: MYTOLAC lanreotide (as acetate) 120 mg solution for injection pre-filled syringe
Artg Id: 371879
Artg Name: MYTOLAC lanreotide (as acetate) 120 mg solution for injection pre-filled syringe
Sponsor: Amdipharm Mercury Australia Pty Ltd
Company Detail Path: /organization/amdipharm-mercury-australia-pty-ltd
Artg Date: 2022-08-10
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/4a720723ae149b51902409de3d5af888.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/7937ab0c882cd986dc74f51bdccc589d.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

d4746129aa484191

Type

Standard